Arrhythmogenic cardiomyopathy
Information
- Disease name
- Arrhythmogenic cardiomyopathy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05569356 | Not yet recruiting | Diagnostic Contribution, Prognosis and Physiopathological Aspects in Arrhythmogenic Cardiomyopathy. (ACORE) | October 20, 2022 | October 20, 2032 | |
| NCT06174220 | Not yet recruiting | Phase 2 | Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy | April 1, 2024 | July 1, 2026 |
| NCT06352307 | Not yet recruiting | Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy | December 31, 2024 | August 31, 2032 | |
| NCT06109181 | Recruiting | Phase 1/Phase 2 | Gene Therapy for ACM Due to a PKP2 Pathogenic Variant | February 29, 2024 | February 2027 |
| NCT06275893 | Recruiting | Phase 1/Phase 2 | IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy | March 29, 2024 | August 1, 2025 |
| NCT04895540 | Unknown status | South Asian Arrhythmogenic Cardiomyopathy Registry | April 10, 2021 | May 1, 2022 |